Table 3.
Dependent variable: Δ BAT activity (1-h after cold exposure) | ||||||
---|---|---|---|---|---|---|
Total (n =14) | Beta-conglycinin (n =8) | Placebo (n = 6) | ||||
r | P | r | P | r | P | |
Δ BMI (kg/m²) | 0.356 | 0.211 | 0.335 | 0.417 | 0.430 | 0.394 |
Δ Body fat (%) | -0.119 | 0.685 | -0.167 | 0.693 | 0.074 | 0.889 |
Serum metabolic parameters | ||||||
Δ Glucose (mg/dL) | 0.188 | 0.519 | 0.411 | 0.312 | -0.297 | 0.568 |
Δ Triglyceride (mg/dL) | 0.191 | 0.514 | 0.162 | 0.702 | 0.265 | 0.612 |
Δ AST (U/I) | 0.355 | 0.212 | 0.497 | 0.210 | -0.616 | 0.192 |
Δ ALT (U/I) | 0.222 | 0.445 | 0.256 | 0.541 | 0.654 | 0.159 |
Δ FGF21 (pg/mL) | 0.591 | 0.026 | 0.718 | 0.045 | 0.046 | 0.932 |
Energy and nutrients intake (/day) | ||||||
Δ Energy (kcal) | -0.117 | 0.690 | -0.343 | 0.405 | 0.232 | 0.658 |
Δ Protein (g) | -0.230 | 0.428 | -0.468 | 0.242 | 0.185 | 0.726 |
Δ Fat (g) | -0.247 | 0.394 | -0.783 | 0.022 | 0.344 | 0.504 |
Δ Carbohydrate (g) | -0.045 | 0.878 | -0.130 | 0.758 | 0.217 | 0.679 |
BAT, brown adipose tissue; BMI, body mass index; AST, aspartate aminotransferase; ALT, alanine aminotransferase; FGF21, fibroblast growth factor 21. Data are the Pearson’s correlation coefficients. Boldface indicates significance.